Last update 08 May 2025

20 valent pneumococcal polysaccharide conjugate vaccine (Minhai Biological)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication
Pneumococcal Infections
Inactive Indication-
Originator Organization
Beijing Minhai Biological Technology Co., Ltd.Beijing Minhai Biological Technology Co., Ltd.
Active Organization
Beijing Minhai Biological Technology Co., Ltd.Beijing Minhai Biological Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with 20 valent pneumococcal polysaccharide conjugate vaccine (Minhai Biological)
CTR20251041
/ RecruitingPhase 2
评价20价肺炎球菌多糖结合疫苗应用于2月龄至5岁健康人群安全性和免疫原性的Ⅱ期临床试验
[Translation] Phase II clinical trial to evaluate the safety and immunogenicity of 20-valent pneumococcal polysaccharide conjugate vaccine in healthy subjects aged 2 months to 5 years
CTR20244371
/ RecruitingPhase 1
评价20价肺炎球菌多糖结合疫苗应用于2月龄及以上健康人群安全性的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety of 20-valent pneumococcal polysaccharide conjugate vaccine in healthy people aged 2 months and above
100 Clinical Results associated with 20 valent pneumococcal polysaccharide conjugate vaccine (Minhai Biological)
Login to view more data
100 Translational Medicine associated with 20 valent pneumococcal polysaccharide conjugate vaccine (Minhai Biological)
Login to view more data
100 Patents (Medical) associated with 20 valent pneumococcal polysaccharide conjugate vaccine (Minhai Biological)
Login to view more data
100 Deals associated with 20 valent pneumococcal polysaccharide conjugate vaccine (Minhai Biological)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pneumococcal InfectionsPhase 2
China
Beijing Minhai Biological Technology Co., Ltd.Beijing Minhai Biological Technology Co., Ltd.
30 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free